Nivolumab plus brentuximab vedotin for relapsed/refractory peripheral T-cell lymphoma and cutaneous T-cell lymphoma.
Loading...
Embargo End Date
ICR Authors
Authors
Zinzani, PL
Salles, G
Moskowitz, AJ
Santoro, A
Mehta, A
Barr, PM
Mehta-Shah, N
Collins, GP
Ansell, SM
Brody, JD
Domingo-Domenech, E
Johnson, NA
Cunningham, D
Ferrari, S
Lisano, J
Krajewski, J
Wen, R
Akyol, A
Crowe, R
Savage, KJ
Salles, G
Moskowitz, AJ
Santoro, A
Mehta, A
Barr, PM
Mehta-Shah, N
Collins, GP
Ansell, SM
Brody, JD
Domingo-Domenech, E
Johnson, NA
Cunningham, D
Ferrari, S
Lisano, J
Krajewski, J
Wen, R
Akyol, A
Crowe, R
Savage, KJ
Document Type
Journal Article
Date
2024-05-28
Date Accepted
2024-02-28
Abstract
Citation
Blood Advances, 2024, 8 (10), pp. 2400 - 2404
Source Title
Blood Advances
Publisher
ELSEVIER
ISSN
2473-9529
eISSN
2473-9537
2473-9537
2473-9537
Collections
Research Team
Medicine (RMH)